Phytochemical characterization and bioactivity assessment of Avicennia officinalis L. bark extracts

Abstract

The study aimed at phytochemical profiling and evaluating the bioactive potentials of aqueous bark extracts of a mangrove plant Avicennia officinalis by in vitro and in silico techniques. The quantitative phytochemical study exhibited total phenol and total flavonoid content as 16.6 mg GAE/g and 82 mg QE/g respectively. The GC-MS study indicated presence of five major compounds viz. 2,6-dimethoxy phenol; 4-[(1E)-3-hydroxy-1-propenyl)- 2-methoxy phenol; 2,5-dimethoxybenzyl acetate; vitamin-E; stigmasterol. The in silico molecular docking of compounds 2,6-dimethoxy phenol; 2,5-dimethoxy benzene methanol acetate and stigmasterol indicated strong binding interactions, validating the antiradical, antidiabetic, anti-inflammatory and antibacterial activities. The extract exhibited DPPH, ABTS, α-glucosidase and protein denaturation inhibition activities with IC50 values of 112.78, 76.34, 257.4, 99.86 μg/mL respectively suggesting the antioxidant, antidiabetic and anti-inflammatory potential of the plant. The antiglycation study exhibited inhibition of fructosamine and congo red with 50.63% and 64.39% at 200 μg/mL concentration. The biofilm inhibitory concentration required to reduce biofilm coverage by 50% values for the extract was 625 μg/mL. The results provide a basis for new pharmacological avenues and further research of this plant.